SIEVESTACK Trademark

Trademark Overview


On Tuesday, November 19, 2024, a trademark application was filed for SIEVESTACK with the United States Patent and Trademark Office. The USPTO has given the SIEVESTACK trademark a serial number of 98861353. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, May 20, 2025. This trademark is owned by SieveStack, Inc.. The SIEVESTACK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemical preparations for pharmaceutical or medical purposes; chemical reagents for medical purposes

Pharmaceutical drug development services; Pharmaceutical research and drug development using artificial intelligence; Providing temporary use of online non-downloadable software using artificial intelligence (AI) for drug development and research; Software as a service (SAAS) services featuring software using artificial intelligence for discovering, creating, and designing drugs and pharmaceuticals; development of computer platforms for pharmaceutical research and drug development using artificial intelligence; research in the field of artificial intelligence technology for pharmaceutical drug development; Custom design and development of chemicals, chemical reagents, and biochemical assays; chemical research and analysis; drug discovery services
sievestack

General Information


Serial Number98861353
Word MarkSIEVESTACK
Filing DateTuesday, November 19, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, May 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical or medical purposes; chemical reagents for medical purposes
Goods and ServicesPharmaceutical drug development services; Pharmaceutical research and drug development using artificial intelligence; Providing temporary use of online non-downloadable software using artificial intelligence (AI) for drug development and research; Software as a service (SAAS) services featuring software using artificial intelligence for discovering, creating, and designing drugs and pharmaceuticals; development of computer platforms for pharmaceutical research and drug development using artificial intelligence; research in the field of artificial intelligence technology for pharmaceutical drug development; Custom design and development of chemicals, chemical reagents, and biochemical assays; chemical research and analysis; drug discovery services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSieveStack, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94117

Trademark Events


Event DateEvent Description
Tuesday, November 19, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 20, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 20, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2025ASSIGNED TO EXAMINER